Yong Qing Luo
Fortune : 7 M $ au 31/05/2026
Fortune : 7 M $ au 31/05/2026
Yong Qing Luo currently works at Everest Medicines Ltd., as Chief Executive Officer & Executive Director from 2022 and Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd., as President & General Manager from 2020.
Dr. Luo also formerly worked at Novartis AG, as Associate Brand Director from 2007 to 2009, Brii Biosciences Ltd. (China), as President, Executive Director & GM-Greater China from 2021 to 2022, Beijing Novartis Pharma Co. Ltd., as Head-Great China Pharmaceutical Organization from 2009 to 2012, Shanghai Roche Pharmaceuticals Ltd., as Vice President from 2012 to 2016, and Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd., as Global Vice President & General Manager-China from 2016 to 2020.
Dr. Luo received his Masters Business Admin degree in 2006 from China Europe International Business School and doctorate degree in 1992 from Xiangya School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 1 772 397 ( 0,5 % ) | 7 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| EVEREST MEDICINES LIMITED | Directeur Général | 19/09/2022 |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | President | 17/09/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| BRII BIOSCIENCES LIMITED | President | 15/09/2022 |
Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd. | Corporate Officer/Principal | 01/09/2020 |
Shanghai Roche Pharmaceuticals Ltd.
Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes anti-cancer and virus drugs | Corporate Officer/Principal | 01/08/2016 |
Beijing Novartis Pharma Co. Ltd.
Beijing Novartis Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | 01/08/2012 |
| NOVARTIS AG | Corporate Officer/Principal | 01/06/2009 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
China Europe International Business School
China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beijing Novartis Pharma Co. Ltd.
Beijing Novartis Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Xiangya School of Medicine
Xiangya School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Roche Pharmaceuticals Ltd.
Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes anti-cancer and virus drugs | Health Technology |
Everest Medicines Ltd.
Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd. | |
Brii Biosciences Ltd. (China)
Brii Biosciences Ltd. (China) BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national